SHARE: +/-: 0.00 SEK / Bid: 10.60 SEK / Ask: 10.65 SEK / Price: N/A / High: N/A / Low: N/A / Quantity: 0 / Turnover: 0 SEK / 2019-07-19 07:47 (CEST)
 

Business Development

Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.

We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.

For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se